Literature DB >> 14275038

OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY.

L A LLOYD, J W HILTZ.   

Abstract

Ocular complications of long-term chloroquine therapy were observed in 18 of 45 patients so treated. This therapy was used in patients with rheumatoid arthritis, lupus erythematosus, sarcoidosis, discoid lupus and other chronic "collagen disease". Thirteen patients had reversible corneal opacifications, and seven had irreversible retinal changes, with visual loss and visual field defects. Pathological evidence of chloroquine retinopathy was obtained in one patient. Physicians are therefore warned to use this drug only after careful consideration. If it is used, repeated ocular examinations should include assessment of visual acuity, visual fields on a tangent screen and fundus examination through a dilated pupil.

Entities:  

Keywords:  CHLOROQUINE; CORNEAL OPACITY; DRUG THERAPY; EYE DISEASES; OPHTHALMOSCOPY; PATHOLOGY; RETINA; STATISTICS; TOXICOLOGIC REPORT; VISION TESTS; VISUAL FIELDS

Mesh:

Substances:

Year:  1965        PMID: 14275038      PMCID: PMC1928171     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  12 in total

1.  THE PATHOLOGY OF CHLOROQUINE RETINOPATHY.

Authors:  H N BERNSTEIN; J GINSBERG
Journal:  Arch Ophthalmol       Date:  1964-02

2.  Chloroquine retinopathy; a report of eight cases with ERG and dark-adaptation findings.

Authors:  E OKUN; P GOURAS; H BERNSTEIN; L VON SALLMANN
Journal:  Arch Ophthalmol       Date:  1963-01

3.  Anticipation of chloroquine retinopathy.

Authors:  G B ARDEN; A FRIEDMANN; H KOLB
Journal:  Lancet       Date:  1962-06-02       Impact factor: 79.321

4.  [Bilateral paralysis of the abducent nerve as cause of diplopia after the use of chloroquine].

Authors:  F KALSBEEK
Journal:  Ned Tijdschr Geneeskd       Date:  1960-07-23

5.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

6.  The ocular complications of chloroquine therapy.

Authors:  H E HOBBS; C D CALNAN
Journal:  Lancet       Date:  1958-06-07       Impact factor: 79.321

7.  Central scotomata following chloroquine therapy.

Authors:  H REED; A A CAMPBELL
Journal:  Can Med Assoc J       Date:  1962-01-27       Impact factor: 8.262

8.  OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE.

Authors:  H E Hobbs; S P Eadie; F Somerville
Journal:  Br J Ophthalmol       Date:  1961-04       Impact factor: 4.638

9.  Bilateral macular degeneration associated with chloroquine therapy.

Authors:  R PENNER; K SOMERS
Journal:  Am J Ophthalmol       Date:  1962-09       Impact factor: 5.258

10.  Chloroquine (Aralen)-induced retinal damage.

Authors:  R J ELLSWORTH; R W ZELLER
Journal:  Arch Ophthalmol       Date:  1961-08
View more
  9 in total

Review 1.  Approaches for detecting lysosomal alkalinization and impaired degradation in fresh and cultured RPE cells: evidence for a role in retinal degenerations.

Authors:  Sonia Guha; Erin E Coffey; Wennan Lu; Jason C Lim; Jonathan M Beckel; Alan M Laties; Kathleen Boesze-Battaglia; Claire H Mitchell
Journal:  Exp Eye Res       Date:  2014-09       Impact factor: 3.467

2.  Ocular melanosis with special reference to chlorpromazine.

Authors:  M E Cameron
Journal:  Br J Ophthalmol       Date:  1967-05       Impact factor: 4.638

3.  Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis.

Authors:  G B Arden; H Kolb
Journal:  Br Med J       Date:  1966-01-29

4.  Delayed onset of chloroquine retinopathy.

Authors:  H Reed; W Karlinsky
Journal:  Can Med Assoc J       Date:  1967-12-02       Impact factor: 8.262

5.  Chloroquine retinopathy: is there a safe daily dose?

Authors:  J S Marks
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

6.  Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study.

Authors:  C Delage; R Lagacé; J Huard
Journal:  Can Med Assoc J       Date:  1975-05-17       Impact factor: 8.262

7.  Two years' experience of screening for hydroxychloroquine retinopathy.

Authors:  Anne Gobbett; Ajay Kotagiri; Claire Bracewell; Jonathan Smith
Journal:  Eye (Lond)       Date:  2020-07-07       Impact factor: 3.775

Review 8.  Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption.

Authors:  Brendan F Boyce; Jinbo Li; Lianping Xing; Zhenqiang Yao
Journal:  Front Immunol       Date:  2018-09-28       Impact factor: 7.561

Review 9.  Visual electrophysiology in the assessment of toxicity and deficiency states affecting the visual system.

Authors:  Emily K O'Neill; Richard Smith
Journal:  Eye (Lond)       Date:  2021-07-21       Impact factor: 3.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.